𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pluripotency: Toward a gold standard for human ES and iPS cells

✍ Scribed by Kelly P. Smith; Mai X. Luong; Gary S. Stein


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
219 KB
Volume
220
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

With the advent of technologies for the derivation of embryonic stem cells and reprogrammed stem cells, use of the term β€œpluripotent” has become widespread. Despite its increased scientific and political importance, there are ambiguities with this designation and a common standard for experimental approaches that precisely define this state in human cells remains elusive. Recent studies have revealed that reprogramming may occur via many pathways which do not always lead to pluripotency. In addition, the pluripotent state itself appears to be highly dynamic, leading to significant variability in the results of molecular studies. Establishment of a stringent set of criteria for defining pluripotency will be vital for biological studies and potential clinical applications in this rapidly evolving field. In this review, we explore the various definitions of pluripotency, examine the current status of pluripotency testing in the field and provide an analysis of how these assays have been used to establish pluripotency in the scientific literature. J. Cell. Physiol. 220: 21–29, 2009. Β© 2009 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Human hair follicle pluripotent stem (hf
✍ Yasuyuki Amoh; Maho Kanoh; Shiro Niiyama; Yuko Hamada; Katsumasa Kawahara; Yuich πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 291 KB πŸ‘ 1 views

## Abstract The optimal source of stem cells for regenerative medicine is a major question. Embryonic stem (ES) cells have shown promise for pluripotency but have ethical issues and potential to form teratomas. Pluripotent stem cells have been produced from skin cells by either viral‐, plasmid‐ or

Human ES and iPS cells as cell sources f
✍ Dong-Youn Hwang; Dae-Sung Kim; Dong-Wook Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 106 KB

## Abstract Cell therapy using human embryonic stem cells (hESCs) is a promising therapeutic option for Parkinson's disease (PD), an incurable neurodegenerative disease. A prerequisite for clinical application of hESCs for PD is an efficient and strict differentiation of hESCs into midbrain dopamin